Top Markets
Coin of the day
MEDIPOST Co., Ltd. MEDIPOST Co., Ltd.

MEDIPOST Co., Ltd.

078160
Rank in Stocks #17589
Medipost Co., Ltd. is a biotechnology firm dedicated to the creation and... Medipost Co., Ltd. is a biotechnology firm dedicated to the creation and manufacturing of stem cell-based products. Its diverse operations are categorized into several divisions: the Cord Blood Bank, which specializes in the collection and storage of newborn umbilical cord stem cells; Stem Cell Therapy, focused on producing allogeneic stem cell pharmaceuticals; Health Functional Food, offering various vitamins and nutritional supplements; and the Import and Distribution of Natural Cosmetics division, responsible for the sales and marketing of natural cosmetic products sourced from Pevonia Inc. Additionally, the company provides comprehensive Healthcare Services, encompassing bizcare, insu-care, affiliate programs, telehealth, and medical devices, accessible via web, mobile, and call centers. Established on June 26, 2000, by Yoon-Sun Yang and Won-Il Oh, Medipost Co., Ltd. is headquartered in Seongnam, South Korea.
Share Price
$6.02
Market Cap
$235.14M
Change (1 day)
-1.36%
Change (1 year)
-21.24%
Country
KR
Trade MEDIPOST Co., Ltd. (078160)

Category

P/B ratio for MEDIPOST Co., Ltd. (078160)
P/B ratio as of 2026 TTM: 0
According to MEDIPOST Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for MEDIPOST Co., Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.828 -
US
7.5116 -
NL
8.2199 -
US
3.9942 -
AU
- -
CH